Tsuruha Holdings Inc
TSE:3391
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (11.4), the stock would be worth ¥5 235.5 (153% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.5 | ¥2 070 |
0%
|
| 3-Year Average | 11.4 | ¥5 235.5 |
+153%
|
| 5-Year Average | 9.6 | ¥4 412.25 |
+113%
|
| Industry Average | 24.8 | ¥11 408.77 |
+451%
|
| Country Average | 22.4 | ¥10 285.83 |
+397%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
937.7B JPY | 4.5 | 22 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
62B ZAR | 61.2 | 19.2 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.3B ZAR | -45.1 | 25.3 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | -10.3 | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
38.3B BRL | 180.8 | 29.7 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
922.6B JPY | 23.8 | 16.5 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 136.7 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
28.1B CNY | 9.3 | 16.3 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 24.5 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
563.9B JPY | 5.1 | 12.5 | |
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
21.3B CNY | 7.7 | 16.6 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 14.9 |
| Median | 22.4 |
| 70th Percentile | 35 |
| Max | 736 044 589.7 |
Other Multiples
Tsuruha Holdings Inc
Glance View
In the bustling realm of Japanese retail, Tsuruha Holdings Inc. has carved a substantial niche for itself, growing from humble beginnings into one of the country's largest drugstore chains. Founded in 1929, this Sapporo-based company has consistently adapted to the evolving needs of consumers, focusing on pharmaceuticals, cosmetics, and everyday convenience goods. It operates through a network of over a thousand stores across Japan, embracing a suburban strategy to reach customers where they live. This allows Tsuruha to tap into diverse consumer needs efficiently and offer a wide variety of products ranging from over-the-counter medicines to beauty products and daily essentials. Their stores often blend pharmacy services with retail, effectively positioning themselves as a one-stop solution for health and wellness needs. The company's business model is built on leveraging economies of scale, along with strategic procurement and inventory management, ensuring they keep costs low while offering competitive prices. A significant factor in their success is Tsuruha's loyalty program, which connects deeply with customers, encouraging repeat visits through personalized marketing and rewards. Tsuruha Holdings also places a strong emphasis on expanding both organically and through strategic acquisitions, allowing them to integrate smaller regional players into their ecosystem. This continuous expansion not only bolsters their market presence but also enhances purchasing power, thereby driving profitability. In essence, Tsuruha’s ability to remain profitable hinges on its vast retail footprint, customer-centric approach, and operational efficiencies, all of which reinforce its status as a dominant force in the Japanese health and wellness sector.